只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-30 2026-07-31 | IONS IONIS PHARMACEUTICALS INC | Hayden Michael R Director | 买入（P） | 15,000 | US$53.38 | US$800,700.00 | 19,000 | SEC |
| 2026-07-30 2026-07-31 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 644 | US$523.04 | US$336,836.54 | 333,299 | SEC |
| 2026-07-30 2026-07-31 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,486 | US$523.87 | US$778,478.10 | 331,813 | SEC |
| 2026-07-30 2026-07-31 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 4,846 | US$524.88 | US$254.36万 | 326,967 | SEC |
| 2026-07-30 2026-07-31 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,084 | US$525.80 | US$109.58万 | 324,883 | SEC |
| 2026-07-30 2026-07-31 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 400 | US$526.92 | US$210,769.20 | 324,483 | SEC |
| 2026-07-30 2026-07-31 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 40 | US$528.96 | US$21,158.40 | 324,443 | SEC |
| 2026-07-30 2026-07-31 | ACAD ACADIA PHARMACEUTICALS INC | Thompson Elizabeth H.Z. Officer · EVP, Head of Research & Dev | 卖出（S） | 16,508 | US$26.13 | US$431,354.04 | 19,044 | SEC |
| 2026-07-30 2026-07-31 | ACAD ACADIA PHARMACEUTICALS INC | Thompson Elizabeth H.Z. Officer · EVP, Head of Research & Dev | 卖出（S） | 50 | US$26.17 | US$1,308.50 | 18,994 | SEC |
| 2026-07-30 2026-07-30 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn Officer · Chief Scientific Officer | 卖出（S） | 3,847 | US$23.38 | US$89,953.63 | 121,338 | SEC |
| 2026-07-30 2026-07-30 | NRIX Nurix Therapeutics, Inc. | Ring Christine Officer · Chief Legal Officer | 卖出（S） | 3,847 | US$23.38 | US$89,953.63 | 19,912 | SEC |
| 2026-07-30 2026-07-30 | NRIX Nurix Therapeutics, Inc. | van Houte Hans Officer · Chief Financial Officer | 卖出（S） | 2,845 | US$23.38 | US$66,524.07 | 44,927 | SEC |
| 2026-07-30 2026-07-30 | MLPT MapLight Therapeutics, Inc. | Catalyst4, Inc. TenPercentOwner | 买入（P） | 1,000,000 | US$13.00 | US$1300万 | 20,906,689 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | KNSA Kiniksa Pharmaceuticals International, plc | Cole G Bradley Director | 卖出（S） | 3,673 | US$81.43 | US$299,092.39 | 11,672 | SEC |
| 2026-07-29 2026-07-31 | MAZE Maze Therapeutics, Inc. | Dandekar Atul Officer · CSBO | 卖出（S） | 7,100 | US$27.31 | US$193,875.44 | 26,650 | SEC |
| 2026-07-29 2026-07-31 | MAZE Maze Therapeutics, Inc. | Dandekar Atul Officer · CSBO | 卖出（S） | 400 | US$27.89 | US$11,156.00 | 26,250 | SEC |
| 2026-07-29 2026-07-30 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 798 | US$518.25 | US$413,564.62 | 333,145 | SEC |
| 2026-07-29 2026-07-30 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,112 | US$519.29 | US$577,453.15 | 332,033 | SEC |
| 2026-07-29 2026-07-30 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 900 | US$520.40 | US$468,363.78 | 331,133 | SEC |
| 2026-07-29 2026-07-30 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,270 | US$521.32 | US$662,077.80 | 329,863 | SEC |
| 2026-07-29 2026-07-30 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 880 | US$522.51 | US$459,813.11 | 328,983 | SEC |
| 2026-07-29 2026-07-30 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,318 | US$523.63 | US$690,137.75 | 327,665 | SEC |
| 2026-07-29 2026-07-30 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,982 | US$524.47 | US$103.95万 | 325,683 | SEC |
| 2026-07-29 2026-07-30 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,240 | US$525.46 | US$651,574.86 | 324,443 | SEC |
| 2026-07-29 2026-07-30 | ANIP ANI PHARMACEUTICALS INC | CAREY STEPHEN P. Officer · SVP & CFO | 卖出（S） | 2,850 | US$81.36 | US$231,876.00 | 174,693 | SEC |
| 2026-07-29 2026-07-30 | MLPT MapLight Therapeutics, Inc. | Catalyst4, Inc. TenPercentOwner | 买入（P） | 3,000 | US$12.63 | US$37,890.00 | 19,906,689 | SEC |
| 2026-07-29 2026-07-29 | VKTX Viking Therapeutics, Inc. | Mancini Marianna Officer · Chief Operating Officer | 卖出（S） | 18,217 | US$33.47 | US$609,635.55 | 422,760 | SEC |
| 2026-07-29 2026-07-29 | VKTX Viking Therapeutics, Inc. | ZANTE GREG Officer · Chief Financial Officer | 卖出（S） | 21,217 | US$33.47 | US$710,141.48 | 212,204 | SEC |
| 2026-07-29 2026-07-29 | VKTX Viking Therapeutics, Inc. | Lian Brian Director,Officer · President & CEO | 卖出（S） | 148,517 | US$33.32 | US$494.79万 | 2,572,441 | SEC |
| 2026-07-29 2026-07-29 | OTLK Outlook Therapeutics, Inc. | Sukhtian Faisal Ghiath Director | 买入（P） | 95,398 | US$1.05 | US$99,996.18 | 220,972 | SEC |
| 2026-07-29 2026-07-29 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 4,952 | US$14.05 | US$69,571.14 | 860,862 | SEC |
| 2026-07-29 2026-07-29 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 9,524 | US$14.05 | US$133,779.82 | 1,032,540 | SEC |
| 2026-07-28 2026-07-30 | RLAY Relay Therapeutics, Inc. | Bergstrom Donald A Officer · President, R&D | 卖出（S） | 2,237 | US$18.61 | US$41,630.57 | 407,660 | SEC |
| 2026-07-28 2026-07-30 | RLAY Relay Therapeutics, Inc. | Rahmer Peter Officer · See remarks | 卖出（S） | 748 | US$18.61 | US$13,920.28 | 228,165 | SEC |
| 2026-07-28 2026-07-30 | RLAY Relay Therapeutics, Inc. | Catinazzo Thomas Officer · Chief Financial Officer | 卖出（S） | 1,459 | US$18.61 | US$27,151.99 | 158,285 | SEC |
| 2026-07-28 2026-07-30 | KPTI Karyopharm Therapeutics Inc. | Poulton Stuart Officer · EVP, Chief Development Officer | 卖出（S） | 189 | US$7.10 | US$1,341.90 | 94,632 | SEC |
| 2026-07-28 2026-07-30 | NBIX NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V Director | 卖出（S） | 1,250 | US$182.01 | US$227,507.50 | 1,588 | SEC |
| 2026-07-28 2026-07-30 | MLPT MapLight Therapeutics, Inc. | Catalyst4, Inc. TenPercentOwner | 买入（P） | 141,088 | US$10.74 | US$151.55万 | 19,838,552 | SEC |
| 2026-07-28 2026-07-30 | MLPT MapLight Therapeutics, Inc. | Catalyst4, Inc. TenPercentOwner | 买入（P） | 65,137 | US$11.69 | US$761,392.91 | 19,903,689 | SEC |
| 2026-07-28 2026-07-29 | ERII Energy Recovery, Inc. | Yeung William Officer · Chief Legal Officer | 卖出（S） | 2,048 | US$8.56 | US$17,530.88 | 99,291 | SEC |
| 2026-07-28 2026-07-29 | GM General Motors Co | Reuss Mark L Officer · President | 卖出（S） | 71,079 | US$89.97 | US$639.5万 | 92,293 | SEC |
| 2026-07-28 2026-07-29 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 6,622 | US$13.86 | US$91,775.62 | 865,814 | SEC |
| 2026-07-28 2026-07-29 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 10,843 | US$13.78 | US$149,375.34 | 1,042,064 | SEC |
| 2026-07-28 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Aghazadeh Behzad Director,TenPercentOwner,Other | 买入（P） | 7,905 | US$18.25 | US$144,266.25 | 3,088,888 | SEC |
| 2026-07-28 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Avoro Capital Advisors LLC Director,TenPercentOwner,Other | 买入（P） | 7,905 | US$18.25 | US$144,266.25 | 3,088,888 | SEC |
| 2026-07-28 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Avoro Ventures LLC Director,Other | 买入（P） | 7,905 | US$18.25 | US$144,266.25 | 3,088,888 | SEC |
| 2026-07-28 2026-07-28 | FCCO FIRST COMMUNITY CORP /SC/ | Deutsch Fred Joseph Director,Officer · Executive Vice President | 卖出（S） | 5,000 | US$34.53 | US$172,650.00 | 23,468 | SEC |
| 2026-07-28 2026-07-28 | FCCO FIRST COMMUNITY CORP /SC/ | Deutsch Fred Joseph Director,Officer · Executive Vice President | 卖出（S） | 5,000 | US$34.50 | US$172,500.00 | 18,468 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,367 | US$523.15 | US$715,152.06 | 332,576 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 40 | US$532.49 | US$21,299.58 | 324,443 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,074 | US$524.04 | US$562,817.56 | 331,502 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 876 | US$525.02 | US$459,918.05 | 330,626 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,473 | US$526.34 | US$775,294.70 | 329,153 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,369 | US$527.16 | US$721,677.66 | 327,784 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,149 | US$528.20 | US$606,904.56 | 326,635 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 625 | US$529.41 | US$330,882.38 | 326,010 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,124 | US$530.29 | US$596,047.98 | 324,886 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 403 | US$530.97 | US$213,981.03 | 324,483 | SEC |
| 2026-07-28 2026-07-28 | MPLT MapLight Therapeutics, Inc. | Cox Troy Director | 买入（P） | 15,620 | US$9.52 | US$148,702.40 | 15,620 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | ORBIMED ADVISORS LLC Director | 买入（P） | 1,000,000 | US$15.00 | US$1500万 | 1,348,825 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | OrbiMed Capital GP VIII LLC Director | 买入（P） | 1,000,000 | US$15.00 | US$1500万 | 1,348,825 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | GORDON CARL L Director | 买入（P） | 1,000,000 | US$15.00 | US$1500万 | 1,348,825 | SEC |
| 2026-07-27 2026-07-29 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham Director,Officer · Chief Executive Officer | 卖出（S） | 2,203 | US$42.11 | US$92,761.72 | 537,614 | SEC |
| 2026-07-27 2026-07-29 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham Director,Officer · Chief Executive Officer | 卖出（S） | 7 | US$42.74 | US$299.15 | 537,607 | SEC |
| 2026-07-27 2026-07-29 | BEAM Beam Therapeutics Inc. | Simon Amy Officer · Chief Medical Officer | 卖出（S） | 16,667 | US$25.74 | US$429,036.91 | 85,696 | SEC |
| 2026-07-27 2026-07-29 | DYN Dyne Therapeutics, Inc. | Kersten Dirk Director | 卖出（S） | 256,072 | US$25.50 | US$653.05万 | 3,592,184 | SEC |
| 2026-07-27 2026-07-29 | DYN Dyne Therapeutics, Inc. | Kersten Dirk Director | 卖出（S） | 5,388 | US$26.04 | US$140,318.61 | 3,586,796 | SEC |
| 2026-07-27 2026-07-29 | MLTX MoonLake Immunotherapeutics | Reich Kristian Officer · Chief Scientific Officer | 卖出（S） | 1,100 | US$20.00 | US$22,000.00 | 2,711,198 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | AH Bio Fund II, L.P. TenPercentOwner | 买入（P） | 333,333 | US$15.00 | US$500万 | 2,385,075 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | AH Equity Partners Bio II, L.L.C. TenPercentOwner | 买入（P） | 333,333 | US$15.00 | US$500万 | 2,385,075 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | AH Bio Fund III, L.P. TenPercentOwner | 买入（P） | 333,333 | US$15.00 | US$500万 | 2,385,075 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | AH Equity Partners Bio III, L.L.C. TenPercentOwner | 买入（P） | 333,333 | US$15.00 | US$500万 | 2,385,075 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | Andreessen Marc L TenPercentOwner | 买入（P） | 333,333 | US$15.00 | US$500万 | 2,385,075 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | HOROWITZ BENJAMIN A TenPercentOwner | 买入（P） | 333,333 | US$15.00 | US$500万 | 2,385,075 | SEC |
| 2026-07-27 2026-07-29 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 3,282 | US$13.28 | US$43,572.16 | 872,436 | SEC |
| 2026-07-27 2026-07-29 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 8,205 | US$13.28 | US$108,932.86 | 1,052,907 | SEC |
| 2026-07-27 2026-07-29 | AVTX Avalo Therapeutics, Inc. | Doyle Mittie Officer · Chief Medical Officer | 卖出（S） | 1,000 | US$20.00 | US$20,000.00 | 51,776 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 680 | US$525.81 | US$357,551.55 | 333,263 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 890 | US$527.14 | US$469,152.46 | 332,373 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 650 | US$528.51 | US$343,529.55 | 331,723 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,797 | US$529.75 | US$951,959.49 | 329,926 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,121 | US$530.49 | US$594,674.92 | 328,805 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,836 | US$531.65 | US$976,107.20 | 326,969 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,529 | US$532.38 | US$814,004.43 | 325,440 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 957 | US$533.53 | US$510,589.55 | 324,483 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 40 | US$535.04 | US$21,401.60 | 324,443 | SEC |
| 2026-07-24 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Aghazadeh Behzad Director,TenPercentOwner,Other | 买入（P） | 2,333,333 | US$15.00 | US$3500万 | 3,030,983 | SEC |
| 2026-07-24 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Avoro Capital Advisors LLC Director,TenPercentOwner,Other | 买入（P） | 2,333,333 | US$15.00 | US$3500万 | 3,030,983 | SEC |
| 2026-07-24 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Avoro Ventures LLC Director,Other | 买入（P） | 2,333,333 | US$15.00 | US$3500万 | 3,030,983 | SEC |
| 2026-07-24 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Aghazadeh Behzad Director,TenPercentOwner,Other | 买入（P） | 50,000 | US$22.31 | US$111.55万 | 3,080,983 | SEC |
| 2026-07-24 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Avoro Capital Advisors LLC Director,TenPercentOwner,Other | 买入（P） | 50,000 | US$22.31 | US$111.55万 | 3,080,983 | SEC |
| 2026-07-24 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Avoro Ventures LLC Director,Other | 买入（P） | 50,000 | US$22.31 | US$111.55万 | 3,080,983 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ORIC Oric Pharmaceuticals, Inc. | Heyman Richard A. Director | 卖出（S） | 7,000 | US$12.02 | US$84,140.00 | 38,300 | SEC |
| 2026-07-24 2026-07-28 | ORIC Oric Pharmaceuticals, Inc. | Heyman Richard A. Director | 卖出（S） | 6,100 | US$12.02 | US$73,322.00 | 206,672 | SEC |
| 2026-07-24 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 820 | US$528.72 | US$433,548.76 | 333,123 | SEC |
| 2026-07-24 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,285 | US$530.45 | US$121.21万 | 330,838 | SEC |
| 2026-07-24 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,115 | US$531.10 | US$592,178.84 | 329,723 | SEC |
| 2026-07-24 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,719 | US$532.27 | US$144.72万 | 327,004 | SEC |
| 2026-07-24 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,818 | US$533.20 | US$969,355.96 | 325,186 | SEC |
| 2026-07-24 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 630 | US$534.39 | US$336,668.09 | 324,556 | SEC |
| 2026-07-24 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 113 | US$535.03 | US$60,457.89 | 324,443 | SEC |
| 2026-07-24 2026-07-27 | OLMA Olema Pharmaceuticals, Inc. | Harmon Cyrus Director | 卖出（S） | 12,500 | US$11.71 | US$146,425.00 | 702,770 | SEC |
| 2026-07-23 2026-07-27 | SCTX Scribe Therapeutics, Inc. | Lucas Svetlana Officer · Chief Business Officer | 买入（P） | 3,000 | US$15.00 | US$45,000.00 | 3,000 | SEC |
| 2026-07-23 2026-07-27 | OLMA Olema Pharmaceuticals, Inc. | Harmon Cyrus Director | 卖出（S） | 12,500 | US$11.58 | US$144,737.50 | 715,270 | SEC |
| 2026-07-23 2026-07-27 | SCTX Scribe Therapeutics, Inc. | Parrot David Officer · Chief Financial Officer | 买入（P） | 1,333 | US$15.00 | US$19,995.00 | 1,333 | SEC |
| 2026-07-23 2026-07-27 | SCTX Scribe Therapeutics, Inc. | Parrot David Officer · Chief Financial Officer | 买入（P） | 1,333 | US$15.00 | US$19,995.00 | 1,333 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 249 | US$522.87 | US$130,194.85 | 333,694 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 200 | US$531.83 | US$106,366.80 | 324,443 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 339 | US$523.72 | US$177,539.72 | 333,355 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 171 | US$524.86 | US$89,751.18 | 333,184 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 387 | US$525.83 | US$203,496.79 | 332,797 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 552 | US$526.88 | US$290,835.39 | 332,245 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,989 | US$527.77 | US$104.97万 | 330,256 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,133 | US$529.08 | US$112.85万 | 328,123 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,279 | US$529.86 | US$120.75万 | 325,844 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,201 | US$530.84 | US$637,540.16 | 324,643 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-22 2026-07-24 | NTLA Intellia Therapeutics, Inc. | Dulac Edward J III Officer · EVP, Chief Financial Officer | 卖出（S） | 8,111 | US$11.25 | US$91,248.75 | 148,175 | SEC |
| 2026-07-22 2026-07-24 | FSBC FIVE STAR BANCORP | Allbaugh Larry Eugene Director,TenPercentOwner | 买入（P） | 5,682 | US$44.00 | US$250,008.00 | 507,401 | SEC |
| 2026-07-22 2026-07-24 | FSBC FIVE STAR BANCORP | Allbaugh Larry Eugene Director,TenPercentOwner | 买入（P） | 90,909 | US$44.00 | US$400万 | 1,101,687 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 120 | US$524.27 | US$62,912.40 | 333,823 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 107 | US$535.40 | US$57,288.07 | 326,563 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 790 | US$536.49 | US$423,826.63 | 325,773 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 570 | US$537.60 | US$306,433.94 | 325,203 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 680 | US$538.46 | US$366,153.00 | 324,523 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 80 | US$539.47 | US$43,157.60 | 324,443 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 485 | US$526.04 | US$255,130.95 | 333,338 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,610 | US$526.84 | US$137.51万 | 330,728 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,211 | US$527.82 | US$639,188.81 | 329,517 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 874 | US$528.91 | US$462,264.89 | 328,643 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 760 | US$529.80 | US$402,644.50 | 327,883 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 400 | US$531.22 | US$212,489.80 | 327,483 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 489 | US$533.24 | US$260,755.53 | 326,994 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 324 | US$534.19 | US$173,075.94 | 326,670 | SEC |
| 2026-07-22 2026-07-23 | MLTX MoonLake Immunotherapeutics | Reich Kristian Officer · Chief Scientific Officer | 卖出（S） | 2,448 | US$20.00 | US$48,960.00 | 2,712,298 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-22 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 4,952 | US$13.81 | US$68,398.51 | 875,718 | SEC |
| 2026-07-22 2026-07-22 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 9,524 | US$13.71 | US$130,599.75 | 1,061,112 | SEC |
| 2026-07-21 2026-07-23 | ACRV Acrivon Therapeutics, Inc. | Miller Mary Officer · Chief Legal Officer | 卖出（S） | 573 | US$1.76 | US$1,008.48 | 82,194 | SEC |
| 2026-07-21 2026-07-23 | RANI Rani Therapeutics Holdings, Inc. | IMRAN MIR A Director,TenPercentOwner | 买入（P） | 36,000 | US$0.69 | US$24,840.00 | 2,119,334 | SEC |
| 2026-07-21 2026-07-23 | MLTX MoonLake Immunotherapeutics | Reich Kristian Officer · Chief Scientific Officer | 卖出（S） | 50,000 | US$20.02 | US$100.1万 | 2,714,746 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | MLYS Mineralys Therapeutics, Inc. | Warren Eric Officer · Chief Commercial Officer | 卖出（S） | 7,438 | US$26.87 | US$199,885.09 | 38,400 | SEC |
| 2026-07-21 2026-07-22 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 120 | US$524.37 | US$62,923.97 | 333,823 | SEC |
| 2026-07-21 2026-07-22 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 341 | US$535.44 | US$182,585.72 | 325,282 | SEC |
| 2026-07-21 2026-07-22 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 839 | US$536.37 | US$450,017.95 | 324,443 | SEC |
| 2026-07-21 2026-07-22 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 160 | US$526.24 | US$84,198.00 | 333,663 | SEC |
| 2026-07-21 2026-07-22 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 240 | US$527.46 | US$126,590.40 | 333,423 | SEC |
| 2026-07-21 2026-07-22 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 509 | US$529.55 | US$269,541.31 | 332,914 | SEC |
| 2026-07-21 2026-07-22 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,926 | US$530.50 | US$102.17万 | 330,988 | SEC |
| 2026-07-21 2026-07-22 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,605 | US$531.52 | US$138.46万 | 328,383 | SEC |
| 2026-07-21 2026-07-22 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 360 | US$532.47 | US$191,688.41 | 328,023 | SEC |
| 2026-07-21 2026-07-22 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 640 | US$533.58 | US$341,489.79 | 327,383 | SEC |
| 2026-07-21 2026-07-22 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,760 | US$534.61 | US$940,922.05 | 325,623 | SEC |
| 2026-07-21 2026-07-22 | ABEO ABEONA THERAPEUTICS INC. | Vazzano Joseph Walter Officer · Chief Financial Officer | 卖出（S） | 1,478 | US$6.53 | US$9,651.34 | 492,079 | SEC |
| 2026-07-21 2026-07-22 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 4,952 | US$14.33 | US$70,970.58 | 880,670 | SEC |
| 2026-07-21 2026-07-22 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 9,524 | US$14.33 | US$136,475.11 | 1,070,636 | SEC |
| 2026-07-20 2026-07-24 | GDTC CytoMed Therapeutics Ltd | Choo Chee Kong Director,TenPercentOwner | 买入（P） | 100,000 | US$1.50 | US$150,000.00 | 630,324 | SEC |
| 2026-07-20 2026-07-22 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 4,952 | US$13.87 | US$68,684.74 | 885,622 | SEC |
| 2026-07-20 2026-07-22 | MAX MediaAlpha, Inc. | Nonko Eugene Director | 卖出（S） | 9,524 | US$13.82 | US$131,657.87 | 1,080,160 | SEC |
| 2026-07-20 2026-07-21 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,831 | US$529.19 | US$968,944.51 | 332,112 | SEC |
| 2026-07-20 2026-07-21 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 960 | US$529.85 | US$508,656.86 | 331,152 | SEC |
| 2026-07-20 2026-07-21 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,660 | US$531.08 | US$881,587.99 | 329,492 | SEC |
| 2026-07-20 2026-07-21 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,874 | US$532.07 | US$997,104.61 | 327,618 | SEC |
| 2026-07-20 2026-07-21 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,686 | US$533.03 | US$898,683.18 | 325,932 | SEC |
| 2026-07-20 2026-07-21 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 889 | US$534.13 | US$474,838.37 | 325,043 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| JONEU | 196 | 0 | 196 | 100.00% | Q |
| XEUR | 2 | 0 | 2 | 100.00% | Q |
| JNEU | 2,837 | 0 | 2,842.2065 | 99.82% | Q |
| EUIG | 105.4425 | 0 | 110.0944 | 95.77% | Q, N |
| TSEU | 488 | 0 | 530 | 92.08% | Q |
| EUVX | 15,100.2915 | 0 | 19,437.3749 | 77.69% | Q |
| IEUR | 160,988.4904 | 157 | 209,091.7399 | 76.99% | B, Q, N |
| NEU | 49,067.3214 | 0 | 66,426.1986 | 73.87% | B, Q, N |
| EU | 1,165,051.5044 | 1,379 | 1,609,595.2669 | 72.38% | B, Q, N |
| LEU | 184,228.6228 | 147 | 257,799.8418 | 71.46% | B, Q, N |
| FEUS | 104 | 0 | 149.6607 | 69.49% | Q |
| BOEU | 7,863.5674 | 0 | 11,398.2934 | 68.99% | Q, N |
| EUSA | 15,518.4331 | 0 | 24,655.5309 | 62.94% | Q, N |
| GSEU | 1,116.6641 | 0 | 2,018.0964 | 55.33% | Q, N |
| SEUS | 12,832 | 0 | 23,378.012 | 54.89% | Q |
| EUO | 2,264.5316 | 0 | 4,312.4966 | 52.51% | Q |
| IEUS | 582 | 0 | 1,181.8582 | 49.24% | Q |
| EUM | 10,839.8179 | 0 | 22,443.6147 | 48.30% | Q, N |
| EURL | 2,400 | 0 | 5,067.4744 | 47.36% | Q |
| DBEU | 5,514.2489 | 0 | 12,282.4893 | 44.90% | Q |
| EUHY | 3,263.618 | 2 | 7,522.0975 | 43.39% | B, Q, N |
| GMEU | 110,808 | 0 | 258,749.65 | 42.82% | Q |
| EUDA | 59.6503 | 0 | 155.3109 | 38.41% | Q, N |
| EUFN | 176,657.7202 | 0 | 515,725.4058 | 34.25% | B, Q, N |
| DEUS | 1,107 | 0 | 3,265.6696 | 33.90% | Q |
| SPEU | 6,961.9659 | 100 | 20,693.3686 | 33.64% | Q, N |
| BBEU | 32,066.429 | 0 | 97,034.3729 | 33.05% | Q, N |
| EUV | 97,486.8617 | 61 | 308,686.1393 | 31.58% | B, Q, N |
| EUAD | 14,604.5788 | 0 | 48,646.5767 | 30.02% | Q, N |
| LEUX | 2,356 | 0 | 9,001.3069 | 26.17% | Q, N |
| TEUP | 22,242 | 1,530 | 85,560.5891 | 26.00% | B, Q, N |
| VEU | 395,701.0094 | 774 | 1,566,907.1136 | 25.25% | B, Q, N |
| NEUP | 1,601 | 0 | 7,413.6186 | 21.60% | Q, N |
| EURK | 1 | 0 | 6 | 16.67% | Q |
| PBEU | 1,489 | 0 | 29,477.726 | 5.05% | Q |
| EUSB | 791.8386 | 0 | 27,870.9854 | 2.84% | Q |
| FEUZ | 6 | 0 | 383.731 | 1.56% | Q |
| FLEU | 2 | 0 | 2,125.1369 | 0.09% | Q |